Chiesi Nordic
Eva Callert is an experienced marketing professional currently serving as the Nordic Marketing Lead at Chiesi Nordic since August 2013, where responsibilities include driving the marketing organization for the AIR & CARE portfolio. Previous roles include Nordic Senior Product Manager and Nordic Product Manager at MSD, Brand and Customer Manager at Schering Plough, and Product Manager at Comma. Additional experience includes positions as Director of Market Communication and Director of Internet & e-Business at AstraZeneca Sverige, Sales Director at NetDoktor A/S, and Product Manager at Sanofi. Eva's educational background includes a Diploma in Business Administration and Economics from IHM Business School and a nursing degree from Mälardalen University, further supplemented by relevant industry training.
Chiesi Nordic
1 followers
Chiesi is an international, privately-owned pharmaceutical company with its Corporate Head Office based in Parma, Italy. Chiesi is dedicated to the research, development and sales of innovative, therapeutic prescription medicines in the fields of respiratory, neonatology, transplant medicine and rare diseases. Founded in 1935, as a family firm, today, Chiesi spans the globe, employing more than 5000 people in 26 affiliates worldwide and distributes its products in more than 70 countries. In the Nordics, Chiesi Pharma AB employs more than 50 dedicated employees, who are based out of our head office in Central Stockholm, the recently integrated Research and Development Centre at Lidingö outside Stockholm or are part of our experienced field-based sales teams. As with every part of the Chiesi group, we embrace a shared set of values and a common code of ethical conduct. This demands the highest standards of reliability, transparency, and individual accountability in everything we do. It emphasizes the importance of collaborative working, putting people first and exchanging knowledge. Implicit in all of these values is a responsible attitude to the social and environmental impact of our actions. Chiesi is entering important new therapy areas, such as organ transplantation and rare diseases, alongside our treatments for respiratory conditions.